BioCryst Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has BioCryst Pharmaceuticals's balance sheet done over the years? Its assets were worth $516,960,000 last year, which is less than in the previous period. 188% of BioCryst Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $972,488,000, which means an increase by 15% compared compared to last year.
Debt to Assets
| 2014 | 136874000 | 61.23M | 44.74% |
|---|---|---|---|
| 2015 | 124555000 | 76.83M | 61.68% |
| 2016 | 89847000 | 88.26M | 98.24% |
| 2017 | 178259000 | 94.49M | 53.01% |
| 2018 | 146841000 | 97.60M | 66.47% |
| 2019 | 175282000 | 137.03M | 78.18% |
| 2020 | 334715000 | 353.97M | 105.75% |
| 2021 | 588151000 | 695.13M | 118.19% |
| 2022 | 550000000 | 844.59M | 153.56% |
| 2023 | 516960000 | 972.48M | 188.12% |
BCRX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 110.64M | 304.76M | 504.38M | 272.12M | 114.17M | 26.73M | 50.28M | 22.10M | 28.89M | 54.54M |
Short term investments | 278.34M | 119.54M | 3.21M | 28.23M | 22.05M | 77.73M | 64.11M | 32.54M | 22.66M | 18.23M |
Net receivables | 56.95M | 50.59M | 29.41M | 8.64M | 22.14M | 4.29M | 6.11M | 8.76M | 6.24M | 9.49M |
Inventory | 28.68M | 27.53M | 15.79M | 7.03M | 1.55M | 1.64M | -37.79M | 500K | 1.61M | 683K |
Other current assets | 21.34M | 12.58M | 9.98M | 5.52M | 4.42M | 2.39M | 4.87M | 1.43M | 4.37M | 6.39M |
Total current assets | 495.96M | 516.5M | 566.13M | 323.8M | 164.34M | 114.35M | 125.39M | 66.98M | 65.99M | 89.34M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 20.91M | 15.42M | 8.71M | 7.11M | 7.34M | 9.13M | 9.54M | 9.92M | 5.14M | 207K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 18.07M | 6.82M | 0 | 0 | 22.37M | 41.29M | 8.92M | 47.68M | 41.11M |
Other non-current assets | 80K | -33.5M | 6.47M | 3.80M | 3.59M | 978K | 2.02M | 4.01M | 5.73M | 6.20M |
Total non-current assets | 20.99M | 33.5M | 22.01M | 10.91M | 10.93M | 32.48M | 52.86M | 22.86M | 58.56M | 47.53M |
Total assets | 516.96M | 550M | 588.15M | 334.71M | 175.28M | 146.84M | 178.25M | 89.84M | 124.55M | 136.87M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 1.22M | 1.42M | 150K | 2.12M | 221K | 8.48M | 2.02M | 2.16M | 7.08M |
Short term debt | 2.64M | 2.36M | 1.81M | 31.17M | 39.95M | 33.74M | 35.22M | 28.24M | 27.80M | 30M |
Total current liabilities | 149.98M | 105.51M | 103.71M | 105.65M | 92.33M | 69.47M | 74.83M | 54.36M | 64.45M | 57.68M |
| Non-current liabilities: | ||||||||||
Long term debt | 822.5M | 739.08M | 591.41M | 124.71M | 44.69M | 28.07M | 19.50M | 25.48M | 2.37M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 123.60M | 0 | 54K | 155K | 244K | 329K | 0 |
Total non-current liabilities | 822.5M | 739.08M | 591.41M | 248.32M | 44.69M | 28.12M | 19.65M | 33.90M | 12.37M | 3.55M |
Total liabilities | 972.48M | 844.59M | 695.13M | 353.97M | 137.03M | 97.60M | 94.49M | 88.26M | 76.83M | 61.23M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |